Ganglioglioma classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}}{{MC}} | {{CMG}}; {{AE}}{{MC}} | ||
==Overview== | ==Overview== | ||
Ganglioglioma may be classified according to the 2016 World Health Organization Classification of Tumors of the Central Nervous System into grades I and III. | |||
==Classification== | ==Classification== | ||
Revision as of 15:16, 2 August 2019
|
Ganglioglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ganglioglioma classification On the Web |
|
American Roentgen Ray Society Images of Ganglioglioma classification |
|
Risk calculators and risk factors for Ganglioglioma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
Ganglioglioma may be classified according to the 2016 World Health Organization Classification of Tumors of the Central Nervous System into grades I and III.
Classification
According to the 2016 edition of the World Health Organization (WHO) classification of Tumors of the Central Nervous System, ganglioglioma is classified into 2 grades:[1]
- Grade I : lesions with low proliferative potential
- grade III: anaplastic ganglioglioma
Criteria for grade II ganglioglioma have not been defined.
References
- ↑ Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK; et al. (2016). "The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary". Acta Neuropathol. 131 (6): 803–20. doi:10.1007/s00401-016-1545-1. PMID 27157931.